| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.00028 | 1 |